305 related articles for article (PubMed ID: 25388435)
21. Novel interaction of the Z-DNA binding domain of human ADAR1 with the oncogenic c-Myc promoter G-quadruplex.
Kang HJ; Le TV; Kim K; Hur J; Kim KK; Park HJ
J Mol Biol; 2014 Jul; 426(14):2594-604. PubMed ID: 24813121
[TBL] [Abstract][Full Text] [Related]
22. Diarylethynyl amides that recognize the parallel conformation of genomic promoter DNA G-quadruplexes.
Dash J; Shirude PS; Hsu ST; Balasubramanian S
J Am Chem Soc; 2008 Nov; 130(47):15950-6. PubMed ID: 18980309
[TBL] [Abstract][Full Text] [Related]
23. Identification of novel telomeric G-quadruplex-targeting chemical scaffolds through screening of three NCI libraries.
Rahman KM; Tizkova K; Reszka AP; Neidle S; Thurston DE
Bioorg Med Chem Lett; 2012 Apr; 22(8):3006-10. PubMed ID: 22421021
[TBL] [Abstract][Full Text] [Related]
24. Nucleic acids targeted to drugs: SELEX against a quadruplex ligand.
Renaud de la Faverie A; Hamon F; Di Primo C; Largy E; Dausse E; Delaurière L; Landras-Guetta C; Toulmé JJ; Teulade-Fichou MP; Mergny JL
Biochimie; 2011 Aug; 93(8):1357-67. PubMed ID: 21664224
[TBL] [Abstract][Full Text] [Related]
25. Simultaneous Binding of Hybrid Molecules Constructed with Dual DNA-Binding Components to a G-Quadruplex and Its Proximal Duplex.
Asamitsu S; Obata S; Phan AT; Hashiya K; Bando T; Sugiyama H
Chemistry; 2018 Mar; 24(17):4428-4435. PubMed ID: 29380465
[TBL] [Abstract][Full Text] [Related]
26. Structure-based optimization of FDA-approved drug methylene blue as a c-myc G-quadruplex DNA stabilizer.
Chan DS; Yang H; Kwan MH; Cheng Z; Lee P; Bai LP; Jiang ZH; Wong CY; Fong WF; Leung CH; Ma DL
Biochimie; 2011 Jun; 93(6):1055-64. PubMed ID: 21377506
[TBL] [Abstract][Full Text] [Related]
27. Synthesis, structural characterization, and quadruplex DNA binding studies of platinum(II)-terpyridine complexes.
Suntharalingam K; White AJ; Vilar R
Inorg Chem; 2009 Oct; 48(19):9427-35. PubMed ID: 19728717
[TBL] [Abstract][Full Text] [Related]
28. Novel molecular mechanism for actinomycin D activity as an oncogenic promoter G-quadruplex binder.
Kang HJ; Park HJ
Biochemistry; 2009 Aug; 48(31):7392-8. PubMed ID: 19496619
[TBL] [Abstract][Full Text] [Related]
29. Structure of the biologically relevant G-quadruplex in the c-MYC promoter.
Yang D; Hurley LH
Nucleosides Nucleotides Nucleic Acids; 2006; 25(8):951-68. PubMed ID: 16901825
[TBL] [Abstract][Full Text] [Related]
30. Phenanthroline-2,9-bistriazoles as selective G-quadruplex ligands.
Nielsen MC; Larsen AF; Abdikadir FH; Ulven T
Eur J Med Chem; 2014 Jan; 72():119-26. PubMed ID: 24361524
[TBL] [Abstract][Full Text] [Related]
31. Topology specific stabilization of promoter over telomeric G-quadruplex DNAs by bisbenzimidazole carboxamide derivatives.
Dhamodharan V; Harikrishna S; Bhasikuttan AC; Pradeepkumar PI
ACS Chem Biol; 2015 Mar; 10(3):821-33. PubMed ID: 25495750
[TBL] [Abstract][Full Text] [Related]
32. Diminazene or berenil, a classic duplex minor groove binder, binds to G-quadruplexes with low nanomolar dissociation constants and the amidine groups are also critical for G-quadruplex binding.
Zhou J; Le V; Kalia D; Nakayama S; Mikek C; Lewis EA; Sintim HO
Mol Biosyst; 2014 Oct; 10(10):2724-34. PubMed ID: 25096593
[TBL] [Abstract][Full Text] [Related]
33. Assessing the differential affinity of small molecules for noncanonical DNA structures.
Stefan L; Bertrand B; Richard P; Le Gendre P; Denat F; Picquet M; Monchaud D
Chembiochem; 2012 Sep; 13(13):1905-12. PubMed ID: 22930447
[TBL] [Abstract][Full Text] [Related]
34. Furan based cyclic homo-oligopeptides bind G-quadruplex selectively and repress c-MYC transcription.
Agarwal T; Roy S; Chakraborty TK; Maiti S
Bioorg Med Chem Lett; 2010 Aug; 20(15):4346-9. PubMed ID: 20615700
[TBL] [Abstract][Full Text] [Related]
35. Effect of loop orientation on quadruplex-TMPyP4 interaction.
Arora A; Maiti S
J Phys Chem B; 2008 Jul; 112(27):8151-9. PubMed ID: 18553964
[TBL] [Abstract][Full Text] [Related]
36. In silico screening of quadruplex-binding ligands.
Ma DL; Ma VP; Chan DS; Leung KH; Zhong HJ; Leung CH
Methods; 2012 May; 57(1):106-14. PubMed ID: 22391485
[TBL] [Abstract][Full Text] [Related]
37. In silico identification of novel ligands for G-quadruplex in the c-MYC promoter.
Kang HJ; Park HJ
J Comput Aided Mol Des; 2015 Apr; 29(4):339-48. PubMed ID: 25527072
[TBL] [Abstract][Full Text] [Related]
38. Identification and characterization of new DNA G-quadruplex binders selected by a combination of ligand and structure-based virtual screening approaches.
Alcaro S; Musetti C; Distinto S; Casatti M; Zagotto G; Artese A; Parrotta L; Moraca F; Costa G; Ortuso F; Maccioni E; Sissi C
J Med Chem; 2013 Feb; 56(3):843-55. PubMed ID: 23294188
[TBL] [Abstract][Full Text] [Related]
39. Specific Stabilization of c-MYC and c-KIT G-Quadruplex DNA Structures by Indolylmethyleneindanone Scaffolds.
Diveshkumar KV; Sakrikar S; Rosu F; Harikrishna S; Gabelica V; Pradeepkumar PI
Biochemistry; 2016 Jun; 55(25):3571-85. PubMed ID: 27226253
[TBL] [Abstract][Full Text] [Related]
40. Small Molecule Microarrays Enable the Identification of a Selective, Quadruplex-Binding Inhibitor of MYC Expression.
Felsenstein KM; Saunders LB; Simmons JK; Leon E; Calabrese DR; Zhang S; Michalowski A; Gareiss P; Mock BA; Schneekloth JS
ACS Chem Biol; 2016 Jan; 11(1):139-48. PubMed ID: 26462961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
